Gerardo Ferbeyre - Publications

Affiliations: 
Biochemistry Université de Montréal, Montréal, Canada 
Area:
Virology Biology

90 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Del Toro N, Lessard F, Bouchard J, Mobasheri N, Guillon J, Igelmann S, Tardif S, Buffard T, Bourdeau V, Brakier-Gingras L, Ferbeyre G. Cellular Senescence limits Translational Readthrough. Biology Open. PMID 34676390 DOI: 10.1242/bio.058688  0.338
2021 Bury M, Le Calvé B, Ferbeyre G, Blank V, Lessard F. New Insights into CDK Regulators: Novel Opportunities for Cancer Therapy. Trends in Cell Biology. PMID 33676803 DOI: 10.1016/j.tcb.2021.01.010  0.312
2019 Lessard F, Saint-Germain E, Mignacca L, Ferbeyre G. SOCS1: phosphorylation, dimerization and tumor suppression. Oncoscience. 6: 386-389. PMID 31984217 DOI: 10.18632/oncoscience.495  0.335
2019 Bury M, Le Calvé B, Lessard F, Dal Maso T, Saliba J, Michiels C, Ferbeyre G, Blank V. NFE2L3 Controls Colon Cancer Cell Growth through Regulation of DUX4, a CDK1 Inhibitor. Cell Reports. 29: 1469-1481.e9. PMID 31693889 DOI: 10.1016/J.Celrep.2019.09.087  0.436
2019 Gorgoulis V, Adams PD, Alimonti A, Bennett DC, Bischof O, Bishop C, Campisi J, Collado M, Evangelou K, Ferbeyre G, Gil J, Hara E, Krizhanovsky V, Jurk D, Maier AB, et al. Cellular Senescence: Defining a Path Forward. Cell. 179: 813-827. PMID 31675495 DOI: 10.1016/J.Cell.2019.10.005  0.33
2019 Igelmann S, Neubauer HA, Ferbeyre G. STAT3 and STAT5 Activation in Solid Cancers. Cancers. 11. PMID 31557897 DOI: 10.3390/Cancers11101428  0.457
2019 Zhou TE, Zhu T, Rivera JC, Omri S, Tahiri H, Lahaie I, Rouget R, Wirth M, Nattel S, Lodygensky G, Ferbeyre G, Nezhady M, Desjarlais M, Hamel P, Chemtob S. The Inability of the Choroid to Revascularize in Oxygen-Induced Retinopathy Results from Increased P53/mir-Let-7b Activity. The American Journal of Pathology. PMID 31430465 DOI: 10.1016/J.Ajpath.2019.07.009  0.337
2019 Saint-Germain E, Mignacca L, Huot G, Acevedo M, Moineau-Vallée K, Calabrese V, Bourdeau V, Rowell MC, Ilangumaran S, Lessard F, Ferbeyre G. Phosphorylation of SOCS1 inhibits the SOCS1-p53 tumor suppressor axis. Cancer Research. PMID 31101761 DOI: 10.1158/0008-5472.Can-18-1503  0.618
2019 Del Toro N, Fernandez-Ruiz A, Mignacca L, Kalegari P, Rowell MC, Igelmann S, Saint-Germain E, Benfdil M, Lopes-Paciencia S, Brakier-Gingras L, Bourdeau V, Ferbeyre G, Lessard F. Ribosomal protein Rpl22/eL22 regulates the cell cycle by acting as an inhibitor of the CDK4-cyclin D complex. Cell Cycle (Georgetown, Tex.). PMID 30874462 DOI: 10.1080/15384101.2019.1593708  0.436
2019 Lopes-Paciencia S, Saint-Germain E, Rowell MC, Ruiz AF, Kalegari P, Ferbeyre G. The senescence-associated secretory phenotype and its regulation. Cytokine. 117: 15-22. PMID 30776684 DOI: 10.1016/J.Cyto.2019.01.013  0.377
2019 Lessard F, Brakier-Gingras L, Ferbeyre G. Ribosomal Proteins Control Tumor Suppressor Pathways in Response to Nucleolar Stress. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. e1800183. PMID 30706966 DOI: 10.1002/Bies.201800183  0.405
2019 Deschênes-Simard X, Parisotto M, Rowell MC, Le Calvé B, Igelmann S, Moineau-Vallée K, Saint-Germain E, Kalegari P, Bourdeau V, Kottakis F, Bardeesy N, Ferbeyre G. Circumventing senescence is associated with stem cell properties and metformin sensitivity. Aging Cell. e12889. PMID 30614183 DOI: 10.1111/Acel.12889  0.396
2018 Matralis AN, Xanthopoulos D, Huot G, Lopes-Paciencia S, Cole C, de Vries H, Ferbeyre G, Tsantrizos YS. Molecular tools that block maturation of the nuclear lamin A and decelerate cancer cell migration. Bioorganic & Medicinal Chemistry. PMID 30309670 DOI: 10.1016/J.Bmc.2018.10.001  0.397
2018 Hulea L, Gravel SP, Morita M, Cargnello M, Uchenunu O, Im YK, Lehuédé C, Ma EH, Leibovitch M, McLaughlan S, Blouin MJ, Parisotto M, Papavasiliou V, Lavoie C, Larsson O, ... ... Ferbeyre G, et al. Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides. Cell Metabolism. PMID 30244971 DOI: 10.1016/J.Cmet.2018.09.001  0.335
2018 Lessard F, Igelmann S, Trahan C, Huot G, Saint-Germain E, Mignacca L, Del Toro N, Lopes-Paciencia S, Le Calvé B, Montero M, Deschênes-Simard X, Bury M, Moiseeva O, Rowell MC, Zorca CE, ... ... Ferbeyre G, et al. Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway. Nature Cell Biology. PMID 29941930 DOI: 10.1038/S41556-018-0127-Y  0.442
2018 McManus FP, Bourdeau V, Acevedo M, Lopes-Paciencia S, Mignacca L, Lamoliatte F, Rojas Pino JW, Ferbeyre G, Thibault P. Quantitative SUMO proteomics reveals the modulation of several PML nuclear body associated proteins and an anti-senescence function of UBC9. Scientific Reports. 8: 7754. PMID 29773808 DOI: 10.1038/S41598-018-25150-Z  0.357
2018 Rowell M, Deschênes-Simard X, Calvé BL, Lopes-Paciência S, Ruiz AF, Kottakis F, Bardeesy N, Ferbeyre G. Abstract 462: Hyperactivation of ERK/MAPK pathway reduces pancreatic cancer cells' proliferation and tumor progression through phosphoproteome reprogramming Cancer Research. 78: 462-462. DOI: 10.1158/1538-7445.Am2018-462  0.45
2018 Ferbeyre G, Parisotto M, Rowell M, Bourdeau V, Schmitzer AR. Abstract 1864: Pharmacologic inhibition of NAMPT sensitizes pancreatic cancer cells to the antineoplastic effects of metformin Cancer Research. 78: 1864-1864. DOI: 10.1158/1538-7445.Am2018-1864  0.359
2017 Saint-Germain E, Mignacca L, Vernier M, Bobbala D, Ilangumaran S, Ferbeyre G. SOCS1 regulates senescence and ferroptosis by modulating the expression of p53 target genes. Aging. PMID 29081404 DOI: 10.18632/aging.101306  0.345
2017 Ferbeyre G. Aberrant signaling and senescence associated protein degradation. Experimental Gerontology. PMID 28658610 DOI: 10.1016/J.Exger.2017.06.016  0.405
2017 Chevrier M, Bobbala D, Villalobos-Hernandez A, Khan MG, Ramanathan S, Saucier C, Ferbeyre G, Geha S, Ilangumaran S. Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer. Bmc Cancer. 17: 157. PMID 28235401 DOI: 10.1186/S12885-017-3141-8  0.443
2016 Villalobos-Hernandez A, Bobbala D, Kandhi R, Khan MG, Mayhue M, Dubois CM, Ferbeyre G, Saucier C, Ramanathan S, Ilangumaran S. SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma. Prostate Cancer and Prostatic Diseases. PMID 27779203 DOI: 10.1038/Pcan.2016.50  0.408
2016 Bourdeau V, Ferbeyre G. CDK4-CDK6 inhibitors induce autophagy-mediated degradation of DNMT1 and facilitate the senescence antitumor response. Autophagy. 0. PMID 27532423 DOI: 10.1080/15548627.2016.1214779  0.45
2016 Acevedo M, Vernier M, Mignacca L, Lessard F, Huot G, Moiseeva O, Bourdeau V, Ferbeyre G. A CDK4/6-Dependent Epigenetic Mechanism Protects Cancer Cells from PML-induced Senescence. Cancer Research. 76: 3252-64. PMID 27206849 DOI: 10.1158/0008-5472.Can-15-2347  0.474
2016 Mukhopadhyay UK, Cass J, Raptis L, Craig AW, Bourdeau V, Varma S, SenGupta S, Elliott BE, Ferbeyre G. STAT5A is regulated by DNA damage via the tumor suppressor p53. Cytokine. PMID 26876578 DOI: 10.1016/J.Cyto.2016.01.013  0.41
2016 Mignacca L, Saint-Germain E, Benoit A, Bourdeau V, Moro A, Ferbeyre G. Sponges against miR-19 and miR-155 reactivate the p53-Socs1 axis in hematopoietic cancers. Cytokine. PMID 26841929 DOI: 10.1016/J.Cyto.2016.01.015  0.328
2016 Yeganeh M, Gui Y, Kandhi R, Bobbala D, Tobelaim WS, Saucier C, Yoshimura A, Ferbeyre G, Ramanathan S, Ilangumaran S. Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver. Oncogene. PMID 26725321 DOI: 10.1038/Onc.2015.485  0.406
2015 Shrivastava S, Mansure JJ, Almajed W, Cury F, Ferbeyre G, Popovic M, Seuntjens J, Kassouf W. The role of HMGB1 in radio-resistance of bladder cancer. Molecular Cancer Therapeutics. PMID 26719575 DOI: 10.1158/1535-7163.Mct-15-0581  0.386
2015 Tobelaim WS, Beaurivage C, Champagne A, Pomerleau V, Simoneau A, Chababi W, Yeganeh M, Thibault P, Klinck R, Carrier JC, Ferbeyre G, Ilangumaran S, Saucier C. Tumour-promoting role of SOCS1 in colorectal cancer cells. Scientific Reports. 5: 14301. PMID 26391193 DOI: 10.1038/Srep14301  0.402
2015 Moiseeva O, Lessard F, Acevedo-Aquino M, Vernier M, Tsantrizos YS, Ferbeyre G. Mutant lamin A links prophase to a p53 independent senescence program. Cell Cycle (Georgetown, Tex.). 14: 2408-21. PMID 26029982 DOI: 10.1080/15384101.2015.1053671  0.462
2015 Mansure JJ, Almajed WS, Shrivastava S, Cury F, Ferbeyre G, Popovic M, Seuntjens J, Kassouf W. Abstract 3316: The role of high mobility group box 1 in the combination therapy of gemcitabine and radiation in muscle invasive bladder cancer Cancer Research. 75: 3316-3316. DOI: 10.1158/1538-7445.Am2015-3316  0.361
2015 Calvé Bl, Deschenes-Ximard X, Kottakis F, Bourdeau V, Lessard F, Moineau-Vallée K, Saint-Germain E, Fitamant J, Perera RM, Bardeesy N, Ferbeyre G. Abstract 2154: ERK/MAPK pathway inhibits tumorigenesis and cellular reprogramming of pancreatic cancer cells Cancer Research. 75: 2154-2154. DOI: 10.1158/1538-7445.Am2015-2154  0.393
2015 Lessard F, Bourdeau V, Igelmann S, Deschênes-Simard X, Montero M, Ferbeyre G. Abstract 1270: Ribosome biogenesis is reduced by oncogenic stress in normal cells and is sufficient to trigger cellular senescence Cancer Research. 75: 1270-1270. DOI: 10.1158/1538-7445.Am2015-1270  0.319
2014 Deschênes-Simard X, Lessard F, Gaumont-Leclerc MF, Bardeesy N, Ferbeyre G. Cellular senescence and protein degradation: breaking down cancer. Cell Cycle (Georgetown, Tex.). 13: 1840-58. PMID 24866342 DOI: 10.4161/Cc.29335  0.373
2014 Vernier M, Ferbeyre G. Complete senescence: RB and PML share the task. Cell Cycle (Georgetown, Tex.). 13: 696. PMID 24526117 DOI: 10.4161/Cc.28090  0.429
2014 Bourdeau V, Ferbeyre G. Engaging a senescent response to cure leukemia. Nature Medicine. 20: 123-4. PMID 24504403 DOI: 10.1038/Nm.3469  0.39
2014 Deschênes-Simard X, Kottakis F, Meloche S, Ferbeyre G. ERKs in cancer: friends or foes? Cancer Research. 74: 412-9. PMID 24408923 DOI: 10.1158/0008-5472.Can-13-2381  0.467
2014 Huot G, Vernier M, Bourdeau V, Doucet L, Saint-Germain E, Gaumont-Leclerc MF, Moro A, Ferbeyre G. CHES1/FOXN3 regulates cell proliferation by repressing PIM2 and protein biosynthesis. Molecular Biology of the Cell. 25: 554-65. PMID 24403608 DOI: 10.1091/Mbc.E13-02-0110  0.467
2014 Mansure JJ, Shrivastava S, Nassim R, Ferbeyre G, Kassouf W. Abstract 3958: Investigation of HMGB1 as a potential marker for radiation response in muscle invasive bladder cancer Cancer Research. 74: 3958-3958. DOI: 10.1158/1538-7445.Am2014-3958  0.348
2014 Deschênes-Simard X, Kottakis F, Lessard F, Saint-Germain E, Bourdeau V, Bardeesy N, Ferbeyre G. Abstract 3895: Tumor suppressor activity of the ERK/MAPK signaling: inhibition of cell reprogramming by degradation of specific proteins Cancer Research. 74: 3895-3895. DOI: 10.1158/1538-7445.Am2014-3895  0.489
2014 Igelmann S, Deschênes-Simard X, Lessard F, Bourdeau V, Ferbeyre G. Abstract 2248: The implication of STAT3 degradation and its mitochondrial functions in cellular senescence Cancer Research. 74: 2248-2248. DOI: 10.1158/1538-7445.Am2014-2248  0.417
2014 Lessard F, Bourdeau V, Deschênes-Simard X, Igelmann S, Montero M, Ferbeyre G. Abstract 2246: Senescence as a result of impaired ribosome biogenesis Cancer Research. 74: 2246-2246. DOI: 10.1158/1538-7445.Am2014-2246  0.427
2013 Deschênes-Simard X, Gaumont-Leclerc MF, Bourdeau V, Lessard F, Moiseeva O, Forest V, Igelmann S, Mallette FA, Saba-El-Leil MK, Meloche S, Saad F, Mes-Masson AM, Ferbeyre G. Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation. Genes & Development. 27: 900-15. PMID 23599344 DOI: 10.1101/Gad.203984.112  0.453
2013 Moiseeva O, Deschênes-Simard X, St-Germain E, Igelmann S, Huot G, Cadar AE, Bourdeau V, Pollak MN, Ferbeyre G. Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation. Aging Cell. 12: 489-98. PMID 23521863 DOI: 10.1111/Acel.12075  0.359
2013 Deschênes-Simard X, Kottakis F, Lessard F, Bardeesy N, Ferbeyre G. Abstract A09: Downregulation of PI3K signaling by high ERK activity prevents transformation by oncogenic RAS Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-A09  0.447
2013 Koromilas AE, Kamindla R, Papadakis AI, Kazimierczak U, Peidis P, Wang S, Tenkerian C, Krishnamoorthy J, Hatzoglou M, Haj FG, Ferbeyre G, Kaufman RJ. Abstract C51: eIF2alpha phosphorylation determines cell susceptibility to oxidative stress via Akt activation. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-C51  0.387
2012 Algire C, Moiseeva O, Deschênes-Simard X, Amrein L, Petruccelli L, Birman E, Viollet B, Ferbeyre G, Pollak MN. Metformin reduces endogenous reactive oxygen species and associated DNA damage. Cancer Prevention Research (Philadelphia, Pa.). 5: 536-43. PMID 22262811 DOI: 10.1158/1940-6207.Capr-11-0536  0.37
2012 Pollak MN, Algire c, Ferbeyre G. Abstract LB-169: Metformin reduces somatic cell mutation rate by inhibiting mitochondrial ROS production: relevance to cancer prevention Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-169  0.376
2012 Deschênes-Simard X, Gaumont-Leclerc M, Bourdeau V, Moiseeva O, Forest V, Mallette FA, Lessard F, Saad F, Mes-Masson A, Ferbeyre G. Abstract 4166: Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation Cancer Research. 72: 4166-4166. DOI: 10.1158/1538-7445.Am2012-4166  0.46
2012 Aauino MDA, Bourdeau V, Vernier M, Ferbeyre G. Abstract 3952: New advances in regulation of senescence by PML and the PML nuclear bodies Cancer Research. 72: 3952-3952. DOI: 10.1158/1538-7445.Am2012-3952  0.465
2011 Gui Y, Yeganeh M, Ramanathan S, Leblanc C, Pomerleau V, Ferbeyre G, Saucier C, Ilangumaran S. SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes. Journal of Hepatology. 55: 1300-8. PMID 21703184 DOI: 10.1016/J.Jhep.2011.03.027  0.342
2011 Moiseeva O, Bourdeau V, Vernier M, Dabauvalle MC, Ferbeyre G. Retinoblastoma-independent regulation of cell proliferation and senescence by the p53-p21 axis in lamin A /C-depleted cells. Aging Cell. 10: 789-97. PMID 21535365 DOI: 10.1111/J.1474-9726.2011.00719.X  0.446
2011 Boulay PL, Schlienger S, Lewis-Saravalli S, Vitale N, Ferbeyre G, Claing A. ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein. Oncogene. 30: 3846-61. PMID 21478909 DOI: 10.1038/Onc.2011.100  0.424
2011 Vernier M, Bourdeau V, Gaumont-Leclerc MF, Moiseeva O, Bégin V, Saad F, Mes-Masson AM, Ferbeyre G. Regulation of E2Fs and senescence by PML nuclear bodies. Genes & Development. 25: 41-50. PMID 21205865 DOI: 10.1101/Gad.1975111  0.453
2011 Ferbeyre G, Moriggl R. The role of Stat5 transcription factors as tumor suppressors or oncogenes Biochimica Et Biophysica Acta - Reviews On Cancer. 1815: 104-114. PMID 20969928 DOI: 10.1016/J.Bbcan.2010.10.004  0.471
2011 Deschênes-Simard X, Gaumont-Leclerc M, Moiseeva O, Forest V, Bourdeau V, Saad F, Mes-Masson A, Ferbeyre G. Abstract 1061: Context dependent tumor suppressor activity of the ERK pathway explains its inverse correlation with malignancy in prostate neoplasms Cancer Research. 71: 1061-1061. DOI: 10.1158/1538-7445.Am2011-1061  0.455
2010 Mallette FA, Calabrese V, Ilangumaran S, Ferbeyre G. SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence. Aging. 2: 445-52. PMID 20622265 DOI: v2/n7/full/100163.html  0.631
2010 Mallette FA, Moiseeva O, Calabrese V, Mao B, Gaumont-Leclerc MF, Ferbeyre G. Transcriptome analysis and tumor suppressor requirements of STAT5-induced senescence. Annals of the New York Academy of Sciences. 1197: 142-51. PMID 20536843 DOI: 10.1111/J.1749-6632.2010.05192.X  0.648
2010 Roux AE, Arseneault G, Chartrand P, Ferbeyre G, Rokeach LA. A screen for genes involved in respiration control and longevity in Schizosaccharomyces pombe. Annals of the New York Academy of Sciences. 1197: 19-27. PMID 20536828 DOI: 10.1111/J.1749-6632.2010.05198.X  0.301
2010 Ramanathan S, Dubois S, Gagnon J, Leblanc C, Mariathasan S, Ferbeyre G, Rottapel R, Ohashi PS, Ilangumaran S. Regulation of cytokine-driven functional differentiation of CD8 T cells by suppressor of cytokine signaling 1 controls autoimmunity and preserves their proliferative capacity toward foreign antigens. Journal of Immunology (Baltimore, Md. : 1950). 185: 357-66. PMID 20519645 DOI: 10.4049/Jimmunol.1000066  0.334
2010 Roux AE, Chartrand P, Ferbeyre G, Rokeach LA. Fission yeast and other yeasts as emergent models to unravel cellular aging in eukaryotes. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 65: 1-8. PMID 19875745 DOI: 10.1093/Gerona/Glp152  0.311
2010 Bourdeau V, Ferbeyre G. Oncogene-Induced Senescence (OIS) as a cellular response to oncogenic stresses Cellular Senescence and Tumor Suppression. 63-83. DOI: 10.1007/978-1-4419-1075-2_3  0.373
2009 Calabrese V, Mallette FA, Deschênes-Simard X, Ramanathan S, Gagnon J, Moores A, Ilangumaran S, Ferbeyre G. SOCS1 links cytokine signaling to p53 and senescence. Molecular Cell. 36: 754-67. PMID 20005840 DOI: 10.1016/J.Molcel.2009.09.044  0.634
2009 Moiseeva O, Bourdeau V, Roux A, Deschênes-Simard X, Ferbeyre G. Mitochondrial dysfunction contributes to oncogene-induced senescence. Molecular and Cellular Biology. 29: 4495-507. PMID 19528227 DOI: 10.1128/Mcb.01868-08  0.359
2009 Bourdeau V, Baudry D, Ferbeyre G. PML links aberrant cytokine signaling and oncogenic stress to cellular senescence. Frontiers in Bioscience (Landmark Edition). 14: 475-85. PMID 19273079 DOI: 10.2741/3256  0.386
2009 Gaumont-Leclerc MF, Ferbeyre G. [Cytokines prevent tumors via a cell senescence mechanism]. MéDecine Sciences : M/S. 25: 138-40. PMID 19239844 DOI: 10.1051/Medsci/2009252138  0.352
2008 Mallette FA, Ferbeyre G. [The DNA damage response contributes to tumor suppression by sensing oncogenic activity]. MéDecine Sciences : M/S. 24: 29-30. PMID 18198105 DOI: 10.1051/Medsci/200824129  0.354
2008 Calabrese V, Mallette FA, Deschênes-Simard X, Ramanathan S, Gagnon J, Moores A, Ilangumaran S, Ferbeyre G. 171 The suppressor of cytokine signaling 1, a new link between p53, DNA damage and senescence Cytokine. 43: 280. DOI: 10.1016/J.Cyto.2008.07.233  0.579
2007 Mallette FA, Gaumont-Leclerc MF, Huot G, Ferbeyre G. Myc down-regulation as a mechanism to activate the Rb pathway in STAT5A-induced senescence. The Journal of Biological Chemistry. 282: 34938-44. PMID 17913706 DOI: 10.1074/Jbc.M707074200  0.433
2007 Villiard E, Brinkmann H, Moiseeva O, Mallette FA, Ferbeyre G, Roy S. Urodele p53 tolerates amino acid changes found in p53 variants linked to human cancer. Bmc Evolutionary Biology. 7: 180. PMID 17903248 DOI: 10.1186/1471-2148-7-180  0.319
2007 Mallette FA, Ferbeyre G. The DNA damage signaling pathway connects oncogenic stress to cellular senescence. Cell Cycle (Georgetown, Tex.). 6: 1831-6. PMID 17671427 DOI: 10.4161/Cc.6.15.4516  0.442
2007 Mallette FA, Gaumont-Leclerc MF, Ferbeyre G. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes & Development. 21: 43-8. PMID 17210786 DOI: 10.1101/Gad.1487307  0.442
2006 Roux AE, Quissac A, Chartrand P, Ferbeyre G, Rokeach LA. Regulation of chronological aging in Schizosaccharomyces pombe by the protein kinases Pka1 and Sck2. Aging Cell. 5: 345-57. PMID 16822282 DOI: 10.1111/J.1474-9726.2006.00225.X  0.375
2006 Moiseeva O, Mallette FA, Mukhopadhyay UK, Moores A, Ferbeyre G. DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation. Molecular Biology of the Cell. 17: 1583-92. PMID 16436515 DOI: 10.1091/Mbc.E05-09-0858  0.392
2005 Mukhopadhyay UK, Senderowicz AM, Ferbeyre G. RNA silencing of checkpoint regulators sensitizes p53-defective prostate cancer cells to chemotherapy while sparing normal cells. Cancer Research. 65: 2872-81. PMID 15805289 DOI: 10.1158/0008-5472.Can-04-2502  0.427
2004 Gaumont-Leclerc MF, Mukhopadhyay UK, Goumard S, Ferbeyre G. PEA-15 is inhibited by adenovirus E1A and plays a role in ERK nuclear export and Ras-induced senescence. The Journal of Biological Chemistry. 279: 46802-9. PMID 15331596 DOI: 10.1074/Jbc.M403893200  0.372
2004 de Stanchina E, Querido E, Narita M, Davuluri RV, Pandolfi PP, Ferbeyre G, Lowe SW. PML is a direct p53 target that modulates p53 effector functions. Molecular Cell. 13: 523-35. PMID 14992722 DOI: 10.1016/S1097-2765(04)00062-0  0.396
2004 Mallette FA, Goumard S, Gaumont-Leclerc MF, Moiseeva O, Ferbeyre G. Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence. Oncogene. 23: 91-9. PMID 14712214 DOI: 10.1038/Sj.Onc.1206886  0.408
2002 Ferbeyre G. PML a target of translocation in APL is a regulator of cellular senescence Leukemia. 16: 1918-1926. PMID 12357343 DOI: 10.1038/Sj.Leu.2402722  0.415
2002 Ferbeyre G, de Stanchina E, Lin AW, Querido E, McCurrach ME, Hannon GJ, Lowe SW. Oncogenic ras and p53 cooperate to induce cellular senescence. Molecular and Cellular Biology. 22: 3497-508. PMID 11971980 DOI: 10.1128/Mcb.22.10.3497-3508.2002  0.405
2002 Ferbeyre G, Lowe SW. The price of tumour suppression? Nature. 415: 26-7. PMID 11780097 DOI: 10.1038/415026A  0.329
2000 Rojas AA, Vazquez-Tello A, Ferbeyre G, Venanzetti F, Bachmann L, Paquin B, Sbordoni V, Cedergren R. Hammerhead-mediated processing of satellite pDo500 family transcripts from Dolichopoda cave crickets. Nucleic Acids Research. 28: 4037-43. PMID 11024185 DOI: 10.1093/Nar/28.20.4037  0.314
2000 Lowe S, Schmitt C, Ferbeyre G, Lin A, de Stanchina E, Soengas M. p53 action in apoptosis and senescence Breast Cancer Research. 2. DOI: 10.1186/Bcr141  0.309
2000 Ferbeyre G, Stanchina Ed, Querido E, Baptiste N, Prives C, Lowe SW. PML is induced by oncogenic ras and promotes premature senescence Genes & Development. 14: 2015-2027. DOI: 10.1101/Gad.14.16.2015  0.38
1998 de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ, Lowe SW. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes & Development. 12: 2434-42. PMID 9694807 DOI: 10.1101/Gad.12.15.2434  0.423
1998 Ferbeyre G, Smith JM, Cedergren R. Schistosome satellite DNA encodes active hammerhead ribozymes Molecular and Cellular Biology. 18: 3880-3888. PMID 9632772 DOI: 10.1128/Mcb.18.7.3880  0.322
1997 Chen H, Ferbeyre G, Cedergren R. Efficient Hammerhead Ribozyme and Antisense RNA Targeting In A Slow Ribosome Escherichia Coli Mutant Nature Biotechnology. 15: 432-435. PMID 9131620 DOI: 10.1038/Nbt0597-432  0.316
1996 Bratty J, Ferbeyre G, Molinaro C, Cedergren R. Stimulation of mitotic recombination upon transcription from the yeast GAL1 promoter but not from other RNA polymerase I, II and III promoters. Current Genetics. 30: 381-8. PMID 8929389 DOI: 10.1007/S002940050146  0.328
1996 Ferbeyre G, Bratty J, Chen H, Cedergren R. Cell cycle arrest promotes trans-hammerhead ribozyme action in yeast Journal of Biological Chemistry. 271: 19318-19323. PMID 8702616 DOI: 10.1074/Jbc.271.32.19318  0.335
1995 Ferbeyre G, Bratty J, Chen H, Cedergren R. A hammerhead ribozyme inhibits ADE1 gene expression in yeast Gene. 155: 45-50. PMID 7698666 DOI: 10.1016/0378-1119(94)00891-U  0.319
Show low-probability matches.